Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Attovia ATTO-1310 Phase 1b Topline 12-Week Results

Attovia Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing positive topline 12-week results from its Phase 1b study of ATTO-1310 in patients with chronic pruritus and high-itch atopic dermatitis, alongside a report of its third-quarter 2026 financial results.

Nitish Kishor | 09 November 2026

Myomo Q3 2026: Revenue Rises to $12.3M, Deficit Widens

Myomo, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the three and nine months ended September 30, 2026, disclosing revenue growth alongside a widening accumulated deficit and reduced cash position.

Aakashdeep | 09 November 2026

Rocket Lab Files 10-Q for Quarter Ended September 30, 2026

Rocket Lab Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the fiscal quarter ended September 30, 2026.

Anjali Anand | 09 November 2026

Ethan Allen Q1 FY2027: Net Sales Fall to $129.6M

Ethan Allen Interiors Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting first-quarter fiscal 2027 results that included a year-over-year decline in net sales and net income, alongside a $92.2 million cash dividend payment.

Vinay Lochav | 09 November 2026

Bank7 Corp. Posts $30.6M Net Income for Nine Months Ended Sept. 2026

Bank7 Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing financial results for the third quarter and first nine months of fiscal 2026.

Aakashdeep | 09 November 2026

GeneDx Q3 2026: Revenue, Losses, and Balance Sheet

GeneDx Holdings Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting condensed consolidated financial statements and management discussion for the third quarter.

Nitish Kishor | 09 November 2026

Mesa Labs Posts $62.3M Q2 Revenue, Cuts Debt to $131M

Mesa Laboratories, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting second-quarter and first-half financial results for fiscal year 2027.

Aditi Sarkar | 09 November 2026

AMG Reports Q3 2026 Revenue of $595.2M, Shares Fall to 24.7M

Affiliated Managers Group, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting consolidated revenue, earnings, and balance sheet data for the third quarter and first nine months of the fiscal year.

Manish Choudhary | 09 November 2026

Hawthorn Bancshares Q3 2026: Net Income Rises to $7.1M

Hawthorn Bancshares, Inc. filed its Form 10-Q with the SEC on November 9, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, including net income of $7.062 million and total assets of $2.141 billion.

Vinay Lochav | 09 November 2026

International Money Express Files 10-Q for Q3 2026

International Money Express, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission covering the period ended September 30, 2026, disclosing financial statements, management discussion, and risk factors including a pending acquisition by The Western Union Company.

Vinay Lochav | 09 November 2026
Support

Hi! How can we help you today?

Loading…